This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, K.-C. Articles by Huang, S. Search for Related Content PubMed PubMed Citation Articles by Kim, K.-C. Articles by Huang, S.

Inactivation of a Histone Methyltransferase by Mutations in Human Cancers

Program in Cancer Genetics and Epigenetics, Cancer Research Center, The Burnham Institute, La Jolla, California

Histone methyltransferase (HMT)¹ class enzymes that methylate lysine residues of histones or proteins contain a conserved catalytic core termed the SET domain, which shares sequence homology with an independently described sequence motif, the PR domain. Intact PR or SET sequence is required for tumor suppression functions, but it remains unclear whether it is histone methyltransferase activity that underlies tumor suppression. We now show that tumor suppressor RIZ1 (PRDM2) methylates histone H3 on lysine 9, and this activity is reduced by mutations in the PR domain found in human cancers. Also, S-adenosylhomocysteine or methyl donor deficiency inhibits RIZ1 and other H3 lysine 9 methylation activities. These results support the hypothesis that H3 lysine 9 methylation activities of a PR/SET domain have tumor suppression functions and may underlie carcinogenesis associated with dietary methyl donor deficiency.

This article has been cited by other articles:

				L. R. Thomas, H. Miyashita, R. M. Cobb, S. Pierce, M. Tachibana, E. Hobeika, M. Reth, Y. Shinkai, and E. M. Oltz Functional Analysis of Histone Methyltransferase G9a in B and T Lymphocytes J. Immunol., July 1, 2008; 181(1): 485 - 493. [Abstract] [Full Text] [PDF]

				B.-G. Jeon, G. Coppola, S. D Perrault, G.-J. Rho, D. H Betts, and W A. King S-adenosylhomocysteine treatment of adult female fibroblasts alters X-chromosome inactivation and improves in vitro embryo development after somatic cell nuclear transfer Reproduction, June 1, 2008; 135(6): 815 - 828. [Abstract] [Full Text] [PDF]

				Z. Duan, R. E. Person, H.-H. Lee, S. Huang, J. Donadieu, R. Badolato, H. L. Grimes, T. Papayannopoulou, and M. S. Horwitz Epigenetic Regulation of Protein-Coding and MicroRNA Genes by the Gfi1-Interacting Tumor Suppressor PRDM5 Mol. Cell. Biol., October 1, 2007; 27(19): 6889 - 6902. [Abstract] [Full Text] [PDF]

				Y. Watanabe, M. Toyota, Y. Kondo, H. Suzuki, T. Imai, M. Ohe-Toyota, R. Maruyama, M. Nojima, Y. Sasaki, Y. Sekido, et al. PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer Clin. Cancer Res., August 15, 2007; 13(16): 4786 - 4794. [Abstract] [Full Text] [PDF]

				I. P. Pogribny, V. P. Tryndyak, L. Muskhelishvili, I. Rusyn, and S. A. Ross Methyl Deficiency, Alterations in Global Histone Modifications, and Carcinogenesis J. Nutr., January 1, 2007; 137(1): 216S - 222S. [Abstract] [Full Text] [PDF]

				K. G. R. Quinlan, M. Nardini, A. Verger, P. Francescato, P. Yaswen, D. Corda, M. Bolognesi, and M. Crossley Specific Recognition of ZNF217 and Other Zinc Finger Proteins at a Surface Groove of C-Terminal Binding Proteins Mol. Cell. Biol., November 1, 2006; 26(21): 8159 - 8172. [Abstract] [Full Text] [PDF]

				I. P. Pogribny, S. A. Ross, V. P. Tryndyak, M. Pogribna, L. A. Poirier, and T. V. Karpinets Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats Carcinogenesis, June 1, 2006; 27(6): 1180 - 1186. [Abstract] [Full Text] [PDF]

				C. A. Davis, M. Haberland, M. A. Arnold, L. B. Sutherland, O. G. McDonald, J. A. Richardson, G. Childs, S. Harris, G. K. Owens, and E. N. Olson PRISM/PRDM6, a Transcriptional Repressor That Promotes the Proliferative Gene Program in Smooth Muscle Cells. Mol. Cell. Biol., April 1, 2006; 26(7): 2626 - 2636. [Abstract] [Full Text] [PDF]

				H. Jang, J. B. Mason, and S.-W. Choi Genetic and Epigenetic Interactions between Folate and Aging in Carcinogenesis J. Nutr., December 1, 2005; 135(12): 2967S - 2971S. [Abstract] [Full Text] [PDF]

				X.-J. Sun, J. Wei, X.-Y. Wu, M. Hu, L. Wang, H.-H. Wang, Q.-H. Zhang, S.-J. Chen, Q.-H. Huang, and Z. Chen Identification and Characterization of a Novel Human Histone H3 Lysine 36-specific Methyltransferase J. Biol. Chem., October 21, 2005; 280(42): 35261 - 35271. [Abstract] [Full Text] [PDF]

				K. N. Bhalla Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies J. Clin. Oncol., June 10, 2005; 23(17): 3971 - 3993. [Abstract] [Full Text] [PDF]

				R. J. Gibbons Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R85 - R92. [Abstract] [Full Text] [PDF]

				E. Grundberg, T. Carling, H. Brandstrom, S. Huang, E. L. Ribom, O. Ljunggren, H. Mallmin, and A. Kindmark A Deletion Polymorphism in the RIZ Gene, a Female Sex Steroid Hormone Receptor Coactivator, Exhibits Decreased Response to Estrogen in Vitro and Associates with Low Bone Mineral Density in Young Swedish Women J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6173 - 6178. [Abstract] [Full Text] [PDF]

				A. H. Lund and M. van Lohuizen Epigenetics and cancer Genes & Dev., October 1, 2004; 18(19): 2315 - 2335. [Abstract] [Full Text] [PDF]

				T. Carling, K.-C. Kim, X.-H. Yang, J. Gu, X.-K. Zhang, and S. Huang A Histone Methyltransferase Is Required for Maximal Response to Female Sex Hormones Mol. Cell. Biol., August 15, 2004; 24(16): 7032 - 7042. [Abstract] [Full Text] [PDF]